1-8 of 8
Muthu Dhandapani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2045: Mechanistic insights into the role of cAMP-regulated EPAC1 in tumor-induced angiogenesis and metastatic potential in triple-negative breast cancer

Muthu Dhandapani, Aaron Goldman, Naveen Kumar, Peeyush Prasad, Eshna Jash, Itender Singh, Kodaganur S. Gopinath, Krishnamurthy S, Prabhusankar P, Seema Sehrawat
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2045.
https://doi.org/10.1158/1538-7445.AM2018-2045
Published: 01 July 2018
View article titled, Abstract 2045: Mechanistic insights into the role of cAMP-regulated EPAC1 in tumor-induced angiogenesis and metastatic potential in triple-negative breast cancer
Journal Articles

Abstract 3736: Application of patient tumors-derived tumor ecosystem platform for the development of novel HDAC inhibitor in solid cancers

Mallikarjun Sundaram, Baraneedharan Ulaganathan, Muthu Dhandapani, Allen Thayakumar, Pragnashree Mukhopadhyay, Saravanan Thiyagarajan, Biswanath Majumder, Prasad Shivarudriah, H Jagadheshan, Ganesh Sambasivam, Steve Birnbuam, Padhma Radhakrishnan, Pradip K. Majumder
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 3736.
https://doi.org/10.1158/1538-7445.AM2014-3736
Published: 01 October 2014
View article titled, Abstract 3736: Application of patient tumors-derived tumor ecosystem platform for the development of novel HDAC inhibitor in solid cancers
Journal Articles

Abstract 2051: PAT-1102, a novel HDAC inhibitor exhibits potent anti-tumor efficacy in patient-derived refractory solid tumors.

Padhma Radhakrishnan, Muthu Dhandapani, Baraneedharan Ulaganathan, Allen Thayakumar, Saravanan Thiyagarajan, Dency Pinto, D R. Vinod, Biswanath Majumder, Prasad Shivarudriaah, H Jagadheshan, Ganesh Sambasivam, Pradip K. Majumder
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2051.
https://doi.org/10.1158/1538-7445.AM2013-2051
Published: 15 April 2013
View article titled, Abstract 2051: PAT-1102, a novel HDAC inhibitor exhibits potent anti-tumor efficacy in patient-derived refractory solid tumors.
Journal Articles

Abstract 2147: Generation of primary cell lines from advanced colon cancer: a tool for screening novel anticancer molecules.

Rohini Nair, Aninda Basu, Muthu Dhandapani, Biswanath Majumder, Baraneedharan Ulaganathan
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2147.
https://doi.org/10.1158/1538-7445.AM2013-2147
Published: 15 April 2013
View article titled, Abstract 2147: Generation of primary cell lines from advanced colon cancer: a tool for screening novel anticancer molecules.
Journal Articles

Abstract 4947: Inhibition of Rapamycin induced AKT activation elicits differential anti-tumor response in head and neck cancers.

Padhma Radhakrishnan, Ulaganathan Baraneedharan, Muthu Dhandapani, Allen Thyakumar, Dency Pinto, Arun Prasath, Ayyappan Velu, A Kamal, Nilesh Brijwani, Rohini Nair, R Basavaraja, Misti Jain, Saravanan Thiyagarajan, Biswanath Majumder, Mallik Sundaram, Prasad Narayanan, Vikram D. Kekatpure, Pradip K. Majumder
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4947.
https://doi.org/10.1158/1538-7445.AM2013-4947
Published: 15 April 2013
View article titled, Abstract 4947: Inhibition of Rapamycin induced AKT activation elicits differential anti-tumor response in head and neck cancers.
Journal Articles

Abstract 5072: Human tumor derived Oncoprint® platform predicts molecular mechanism of sensitivity and resistance to Fragmin in pancreatic cancer.

Mallikarjun Sundaram, Saravanan Thiyagarajan, Muthu Dhandapani, Nilesh Brijwani, Arun Prasath, Allen Thayakumar, Ameer Kamal, Padhma Radhakrishnan, Biswanath Majumder, Baraneedharan Ulaganathan, Pradip K. Majumder
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5072.
https://doi.org/10.1158/1538-7445.AM2013-5072
Published: 15 April 2013
View article titled, Abstract 5072: Human tumor derived Oncoprint<sup>®</sup> platform predicts molecular mechanism of sensitivity and resistance to Fragmin in pancreatic cancer.
Journal Articles

Inhibition of Rapamycin-Induced AKT Activation Elicits Differential Antitumor Response in Head and Neck Cancers

Padhma Radhakrishnan, Ulaganathan Baraneedharan, Subhadra Veluchamy, Muthu Dhandapani, Dency D. Pinto, Saravanan Thiyagarajan, Allen Thayakumar, Arun Prasath, Kamal A, Ayyappan Velu, Misti Jain, Nilesh Brijwani, Prasad Narayanan, Vikram D. Kekatpure, Biswanath Majumder, Pradip K. Majumder
Journal: Cancer Research
Cancer Res (2013) 73 (3): 1118–1127.
https://doi.org/10.1158/0008-5472.CAN-12-2545
Published: 31 January 2013
View article titled, Inhibition of Rapamycin-Induced AKT Activation Elicits Differential Antitumor Response in Head and Neck Cancers
Open the PDF for Inhibition of Rapamycin-Induced AKT Activation Elicits Differential Antitumor Response in Head and Neck Cancers in another window
Journal Articles

Abstract 3191: Primary human tumor-derived Oncoprint platform predicts molecular mechanism of sensitivity and resistance to anti-EGFR in colorectal cancer: A step towards personalized cancer medicine

Misti Jain, Farrah Zahed, Arun Prasath, Muthu Dhandapani, Subhadra Veluchamy, A Kamal, Padhma Radhakrishnan, Saravanan Thiyagarajan, Rajagopalan Surendran, Biswanath Mazumder, Mallik Sundaram, Pradip K. Majumder
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3191.
https://doi.org/10.1158/1538-7445.AM2012-3191
Published: 15 April 2012
View article titled, Abstract 3191: Primary human tumor-derived Oncoprint platform predicts molecular mechanism of sensitivity and resistance to anti-EGFR in colorectal cancer: A step towards personalized cancer medicine